One possible explanation was offered by Ozdogan and co-authors describing a downregulation of the ribonuclease III enzymes DICER and DROSHA in MDS specimen, which was even more pronounced in BM samples from sAML patients [46]. The gene discussed is DROSHA; the disease is myelodysplastic syndrome.